Post-earnings recap
Reported
Mon, Feb 1, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a slight miss on EPS, which contributed to a 6.04% drop in stock price. The lack of revenue data and guidance may raise concerns among investors about future performance. Management's defensive tone suggests they are facing challenges in the market, which could impact growth moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | -0.98% |
Management expressed concerns about market conditions impacting performance. They are prioritizing efficiency to navigate these challenges.
Management acknowledged challenges in the current market environment.
They emphasized a focus on operational efficiency moving forward.